Could This Non-Profit Drugmaker Solve the U.S. Insulin Crisis?

It’s planning to produce the diabetes drug at no more than $30 for a month’s supply—a fraction of some private pharma companies.

Jing Luo, The Conversation

Published May 9 2022 1:27PM EDT 

Jing Luo, The Conversation

Got a tip? Send it to The Daily Beast here.